OnOctober31,2005,PfizerannouncedtheofficialopeningofChinaResearchandDevelopmentCenter(CRDC)inShanghai.PfizerGlobalResearchandDevelopment’sCenterismainlyengagedindrugdevelopmentactivities.Muchofthefacility'scapacityisdevotedtothestudydesign,datamanagementandstatisticalanalysisofglobalphaseI-IVclinicaltrials,aswellastheclinicalstudyreportprocess.Inaddition,CRDCisapartofPfizerglobalSafetyandRiskManagementandcoversthefunctionsofsafetydataprocessingandassessment.ThecenteralsotrainsPfizeremployeesinChinaandthroughouttheAsiaregionininternationallyrecognizedGoodClinicalPracticestandards.辉瑞公司于2005年10月31日宣布辉瑞中国研发中心正式在上海揭幕。辉瑞中国研发中心主要为全球辉瑞药物开发提供支持工作。大部分的功能是围绕在I-IV期临床试验研究设计、数据管理和生物统计分析、以及临床试验报告的部分准备工作。此外，该中心是辉瑞全球安全和风险管理部的一个分支，负责安全数据处理和评估工作。研发中心还将为辉瑞公司在中国及亚洲的其它运营部门的员工提供国际标准的临床试验管理规范(GCP)的技术培训。
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
